Stay updated on Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Sign up to get notified when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.

Latest updates to the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page
- Check5 days agoChange DetectedThe footer’s ClinicalTrials.gov revision label changed from v3.7.0 to v3.7.1.SummaryDifference0.2%

- Check12 days agoNo Change Detected
- Check19 days agoNo Change Detected
- Check26 days agoChange Detected- The page now renders a 403 Forbidden error instead of the study record content, blocking access to the trial details and documents.SummaryDifference17%

- Check33 days agoChange DetectedIsrael study site list updated: Tel Litwinsky added as a study location and Qiryat Krinitzi removed. This changes the enrollment options for participants in Israel.SummaryDifference0.1%

- Check40 days agoChange DetectedTel Litwinsky, Israel was removed and Qiryat Krinitzi, Israel was added as recruitment sites, updating the study's Israel-based site network. This change reflects a shift in the participating centers within the country.SummaryDifference0.1%

- Check47 days agoChange DetectedThe page revision tag was updated from v3.6.5 to v3.6.6, indicating a new version of the page template. This reflects a maintenance/update to the page infrastructure rather than substantive content changes.SummaryDifference0.0%

- Check68 days agoChange DetectedAn added revision entry shows the current version as v3.6.5 and the previous version v3.6.4 is removed from the history. This update reflects a new baseline in the revision log.SummaryDifference0.0%

Stay in the know with updates to Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Olaparib Maintenance in BRCA Ovarian Cancer Clinical Trial page.